The robotic surgical companion market size has grown rapidly in recent years. It will grow from $6.9 billion in 2025 to $7.86 billion in 2026 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to shortage of skilled surgeons, rising surgical complexity, demand for minimally invasive procedures, technological advances in robotics, hospital investment in advanced surgery.
The robotic surgical companion market size is expected to see rapid growth in the next few years. It will grow to $13.07 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to AI-enabled surgical assistance, expansion of robotic surgery training, growing outpatient surgeries, demand for faster patient recovery, integration with imaging systems. Major trends in the forecast period include precision-assisted surgical procedures, minimally invasive robotic surgery, surgeon guidance and decision support, enhanced surgical dexterity systems, operating room workflow optimization.
The increasing incidence of cancer is expected to drive the growth of the robotic surgical companion market in the coming years. Cancer is a disease characterized by the uncontrolled multiplication of abnormal cells that can invade nearby tissues and spread to other parts of the body. The rise in cancer cases is largely attributed to unhealthy lifestyle habits such as poor diet, lack of physical activity, and tobacco use, which heighten the risk of cell damage and abnormal growth. Robotic surgical companions play a crucial role in cancer treatment by enabling highly precise and minimally invasive procedures that minimize damage to healthy tissues and support faster recovery. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that the number of new cancer cases is projected to surpass 35 million by 2050, representing a 77% increase compared to approximately 20 million cases in 2022. Therefore, the growing prevalence of cancer is contributing to the expansion of the robotic surgical companion market.
Leading companies in the robotic surgical companion market are emphasizing technological advancements, particularly in AI-powered robotic surgery systems, to enhance surgical precision, reduce operating time, and improve patient outcomes. An AI-powered robotic surgery system combines artificial intelligence algorithms with robotic instruments to assist surgeons in planning, guiding, and executing procedures with greater accuracy and efficiency. For example, in July 2025, CARE Hospitals, an India-based healthcare provider, introduced the Stryker Mako Robotic System to improve precision in orthopedic surgeries. This advanced AI-based technology enables highly accurate and personalized joint replacement surgeries using detailed 3D modeling and real-time robotic assistance. Its key advantages include enhanced surgical accuracy, reduced tissue trauma, less postoperative pain, faster recovery, and more predictable outcomes. The system aims to improve the quality and consistency of orthopedic surgeries, supporting better long-term joint function with shorter hospital stays and fewer complications compared to conventional techniques.
In October 2025, Zimmer Biomet Holdings Inc., a US-based medical device company, acquired Monogram Technologies Inc. for an undisclosed amount. This acquisition aims to strengthen Zimmer Biomet’s leadership in orthopedic surgery innovation by incorporating Monogram’s AI-driven technologies to create the first fully autonomous robotic surgical solutions. The move expands Zimmer Biomet’s robotics portfolio and provides surgeons with a more comprehensive and advanced robotic ecosystem to improve surgical outcomes. Monogram Technologies Inc. is a US-based medical device company specializing in robotic surgical companions.
Major companies operating in the robotic surgical companion market are Intuitive Surgical Inc., Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Asensus Surgical Inc., Globus Medical Inc., Distalmotion SA, Medicaroid Corporation, CMR Surgical Ltd., Johnson & Johnson, Smith & Nephew plc, eCential Robotics SAS, Renishaw plc, Meere Company Inc., avateramedical GmbH, Robocath SAS, Preceyes B.V., Neocis Inc., Microbot Medical Inc., NDR Medical Technology Pte. Ltd., Accuray Incorporated.
North America was the largest region in the robotic surgical companion market in 2025. The regions covered in the robotic surgical companion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robotic surgical companion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of robotic arms, precision sensors, control systems, and imaging components used in robotic surgical companions. The impact is strongest in hardware-intensive surgical robots manufactured in Asia-Pacific and deployed in North America and Europe. Although tariffs have raised capital costs and slowed adoption, they have also promoted domestic manufacturing, modular system design, and strategic partnerships to improve cost efficiency.
The robotic surgical companion market research report is one of a series of new reports that provides robotic surgical companion market statistics, including robotic surgical companion industry global market size, regional shares, competitors with a robotic surgical companion market share, detailed robotic surgical companion market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgical companion industry. This robotic surgical companion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A robotic surgical companion refers to an advanced robotic system that assists surgeons during surgical procedures by offering precision, improved dexterity, and real-time guidance, which enhances surgical outcomes and minimizes procedural risks. It also simplifies complex surgical tasks, enabling minimally invasive techniques and promoting faster patient recovery.
The main components of robotic surgical companions include hardware, software, and services. Hardware consists of the physical components that form the robotic system, encompassing product types such as surgical robots, robotic surgical assistants, robotic navigation systems, and others. These systems are utilized in various applications, including general surgery, urology, gynecology, orthopedics, cardiovascular surgery, neurosurgery, and others, and are employed by end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.
The robotic surgical companion market consists of revenues earned by entities providing services such as robotic-assisted surgery, surgical planning and navigation support, real-time intraoperative guidance, system maintenance and software updates, and training and simulation for surgeons. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic surgical companion market also includes sales of robotic instrument holders, robotic endoscopic systems, and haptic feedback devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The robotic surgical companion market size is expected to see rapid growth in the next few years. It will grow to $13.07 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to AI-enabled surgical assistance, expansion of robotic surgery training, growing outpatient surgeries, demand for faster patient recovery, integration with imaging systems. Major trends in the forecast period include precision-assisted surgical procedures, minimally invasive robotic surgery, surgeon guidance and decision support, enhanced surgical dexterity systems, operating room workflow optimization.
The increasing incidence of cancer is expected to drive the growth of the robotic surgical companion market in the coming years. Cancer is a disease characterized by the uncontrolled multiplication of abnormal cells that can invade nearby tissues and spread to other parts of the body. The rise in cancer cases is largely attributed to unhealthy lifestyle habits such as poor diet, lack of physical activity, and tobacco use, which heighten the risk of cell damage and abnormal growth. Robotic surgical companions play a crucial role in cancer treatment by enabling highly precise and minimally invasive procedures that minimize damage to healthy tissues and support faster recovery. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that the number of new cancer cases is projected to surpass 35 million by 2050, representing a 77% increase compared to approximately 20 million cases in 2022. Therefore, the growing prevalence of cancer is contributing to the expansion of the robotic surgical companion market.
Leading companies in the robotic surgical companion market are emphasizing technological advancements, particularly in AI-powered robotic surgery systems, to enhance surgical precision, reduce operating time, and improve patient outcomes. An AI-powered robotic surgery system combines artificial intelligence algorithms with robotic instruments to assist surgeons in planning, guiding, and executing procedures with greater accuracy and efficiency. For example, in July 2025, CARE Hospitals, an India-based healthcare provider, introduced the Stryker Mako Robotic System to improve precision in orthopedic surgeries. This advanced AI-based technology enables highly accurate and personalized joint replacement surgeries using detailed 3D modeling and real-time robotic assistance. Its key advantages include enhanced surgical accuracy, reduced tissue trauma, less postoperative pain, faster recovery, and more predictable outcomes. The system aims to improve the quality and consistency of orthopedic surgeries, supporting better long-term joint function with shorter hospital stays and fewer complications compared to conventional techniques.
In October 2025, Zimmer Biomet Holdings Inc., a US-based medical device company, acquired Monogram Technologies Inc. for an undisclosed amount. This acquisition aims to strengthen Zimmer Biomet’s leadership in orthopedic surgery innovation by incorporating Monogram’s AI-driven technologies to create the first fully autonomous robotic surgical solutions. The move expands Zimmer Biomet’s robotics portfolio and provides surgeons with a more comprehensive and advanced robotic ecosystem to improve surgical outcomes. Monogram Technologies Inc. is a US-based medical device company specializing in robotic surgical companions.
Major companies operating in the robotic surgical companion market are Intuitive Surgical Inc., Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Asensus Surgical Inc., Globus Medical Inc., Distalmotion SA, Medicaroid Corporation, CMR Surgical Ltd., Johnson & Johnson, Smith & Nephew plc, eCential Robotics SAS, Renishaw plc, Meere Company Inc., avateramedical GmbH, Robocath SAS, Preceyes B.V., Neocis Inc., Microbot Medical Inc., NDR Medical Technology Pte. Ltd., Accuray Incorporated.
North America was the largest region in the robotic surgical companion market in 2025. The regions covered in the robotic surgical companion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robotic surgical companion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of robotic arms, precision sensors, control systems, and imaging components used in robotic surgical companions. The impact is strongest in hardware-intensive surgical robots manufactured in Asia-Pacific and deployed in North America and Europe. Although tariffs have raised capital costs and slowed adoption, they have also promoted domestic manufacturing, modular system design, and strategic partnerships to improve cost efficiency.
The robotic surgical companion market research report is one of a series of new reports that provides robotic surgical companion market statistics, including robotic surgical companion industry global market size, regional shares, competitors with a robotic surgical companion market share, detailed robotic surgical companion market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgical companion industry. This robotic surgical companion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A robotic surgical companion refers to an advanced robotic system that assists surgeons during surgical procedures by offering precision, improved dexterity, and real-time guidance, which enhances surgical outcomes and minimizes procedural risks. It also simplifies complex surgical tasks, enabling minimally invasive techniques and promoting faster patient recovery.
The main components of robotic surgical companions include hardware, software, and services. Hardware consists of the physical components that form the robotic system, encompassing product types such as surgical robots, robotic surgical assistants, robotic navigation systems, and others. These systems are utilized in various applications, including general surgery, urology, gynecology, orthopedics, cardiovascular surgery, neurosurgery, and others, and are employed by end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.
The robotic surgical companion market consists of revenues earned by entities providing services such as robotic-assisted surgery, surgical planning and navigation support, real-time intraoperative guidance, system maintenance and software updates, and training and simulation for surgeons. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic surgical companion market also includes sales of robotic instrument holders, robotic endoscopic systems, and haptic feedback devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Robotic Surgical Companion Market Characteristics
3. Robotic Surgical Companion Market Supply Chain Analysis
4. Global Robotic Surgical Companion Market Trends and Strategies
5. Robotic Surgical Companion Market Analysis of End Use Industries
7. Global Robotic Surgical Companion Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Robotic Surgical Companion Total Addressable Market (TAM) Analysis for the Market
9. Robotic Surgical Companion Market Segmentation
10. Robotic Surgical Companion Market Regional and Country Analysis
11. Asia-Pacific Robotic Surgical Companion Market
12. China Robotic Surgical Companion Market
13. India Robotic Surgical Companion Market
14. Japan Robotic Surgical Companion Market
15. Australia Robotic Surgical Companion Market
16. Indonesia Robotic Surgical Companion Market
17. South Korea Robotic Surgical Companion Market
18. Taiwan Robotic Surgical Companion Market
19. South East Asia Robotic Surgical Companion Market
20. Western Europe Robotic Surgical Companion Market
21. UK Robotic Surgical Companion Market
22. Germany Robotic Surgical Companion Market
23. France Robotic Surgical Companion Market
24. Italy Robotic Surgical Companion Market
25. Spain Robotic Surgical Companion Market
26. Eastern Europe Robotic Surgical Companion Market
27. Russia Robotic Surgical Companion Market
28. North America Robotic Surgical Companion Market
29. USA Robotic Surgical Companion Market
30. Canada Robotic Surgical Companion Market
31. South America Robotic Surgical Companion Market
32. Brazil Robotic Surgical Companion Market
33. Middle East Robotic Surgical Companion Market
34. Africa Robotic Surgical Companion Market
36. Robotic Surgical Companion Market Competitive Landscape and Company Profiles
37. Robotic Surgical Companion Market Other Major and Innovative Companies
40. Robotic Surgical Companion Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Robotic Surgical Companion Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses robotic surgical companion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for robotic surgical companion? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robotic surgical companion market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Hardware; Software; Services2) By Product Type: Surgical Robots; Robotic Surgical Assistants; Robotic Navigation Systems; Other Product Types
3) By Application: General Surgery; Urology; Gynecology; Orthopedics; Cardiovascular; Neurosurgery; Other Applications
4) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
Subsegments:
1) By Hardware: Surgical Robots; Accessories And Consumables2) By Software: Surgical Planning Software Artificial Intelligence And Analytics Software; Imaging And Navigation Software
3) By Services: Maintenance And Support; Remote Monitoring And Upgrades; Training And Consulting
Companies Mentioned: Intuitive Surgical Inc.; Medtronic plc; Stryker Corporation; Zimmer Biomet Holdings Inc.; Asensus Surgical Inc.; Globus Medical Inc.; Distalmotion SA; Medicaroid Corporation; CMR Surgical Ltd.; Johnson & Johnson; Smith & Nephew plc; eCential Robotics SAS; Renishaw plc; Meere Company Inc.; avateramedical GmbH; Robocath SAS; Preceyes B.V.; Neocis Inc.; Microbot Medical Inc.; NDR Medical Technology Pte. Ltd.; Accuray Incorporated
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Robotic Surgical Companion market report include:- Intuitive Surgical Inc.
- Medtronic plc
- Stryker Corporation
- Zimmer Biomet Holdings Inc.
- Asensus Surgical Inc.
- Globus Medical Inc.
- Distalmotion SA
- Medicaroid Corporation
- CMR Surgical Ltd.
- Johnson & Johnson
- Smith & Nephew plc
- eCential Robotics SAS
- Renishaw plc
- Meere Company Inc.
- avateramedical GmbH
- Robocath SAS
- Preceyes B.V.
- Neocis Inc.
- Microbot Medical Inc.
- NDR Medical Technology Pte. Ltd.
- Accuray Incorporated
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 7.86 Billion |
| Forecasted Market Value ( USD | $ 13.07 Billion |
| Compound Annual Growth Rate | 13.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
